For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Epigenetic News, Cancer News, Doctor News, Hospital News, Oral Cancer News

BREAKING NEWS
  Nov 11, 2018

Philips HeartStart FR2+ Defibrillator

Philips HeartStart FR2+ Defibrillator
  Nov 11, 2018


The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can deliver its most powerful therapy from the very first shock. There’s no need to hold back.

Capabilities and Features:

  • Automated defibrillation, with manual override (ECG model only)
  • SMART Analysis
  • SMART CPR and Quick Shock
  • Infant/child defibrillation
  • Conscious monitoring with optional FR2+ ECG Assessment Module
  • Optional rechargeable battery
  • Two display options: text-only, and text with ECG
  • Voice and text prompts
  • Over 8 hours of data collection
  • Programmable voice recording
  • Automated self-tests
  • "Ready-for-Use" indicator
  • Long-life battery: 300 shocks (minimum) or 12 hours monitoring
  • Pads can connect to most ALS defibrillator/monitors via pads adapters
For more detail: http://www.medical.philips.com/in_en/products/resuscitation/products/FR2plus/index.wpd
Request a Quote
for Philips HeartStart FR2+ Defibrillator